279:
377:
Michigan in August 1993. The participants voted to charter the organization and this was accomplished the next year with the first AOPT meeting held in New
Orleans, Louisiana in January 1995. The founding board comprised Drs. George Chiou (president), David Lee (vice-president), Hitoshi Shichi (treasurer), and Herbert Kaufman (trustee). During the early FASEB years, Chiou also established the
177:
63:
22:
393:
The mission of AOPT is to help researchers and eye-care professionals in their efforts toward the understanding and the treatment of eye diseases. AOPT scientific dissemination involves preclinical and clinical pharmacologists and researchers. Scientific dissemination is promoted through biennial
376:
AOPT was begun informally in the 1970s by Dr. George Chiou as special sessions at the
Federation of American Societies for Experimental Biology conferences. It grew to an official separate Symposium of Ocular Pharmacology meeting of academicians, clinicians, and pharmaceutical industry at Novi,
458:
AOPT has a diverse leadership and membership which include principal investigators, scientists, medical professionals, technicians, and students with an interest in ocular pharmacology and therapeutics. The directive committee and members come from academic institutions and private companies
799:
356:) is an organization that welcomes members from disciplines related to ocular pharmacology and its therapeutic applications. The mission of AOPT is the sustenance of a scientific network aiming the dissemination of knowledge in the field of
425:
of pharmaceuticals used in the treatment of ocular disorders. The journal is published 10 times per year. This journal is peer reviewed with on line access prior to journal publication and it is available in 170 countries
194:
35:
558:
meeting, in which the latest findings in vision and ophthalmology research are disseminated. Societies in the field of eye research span from preclinical to clinical and a few of these societies are hereby listed:
299:
41:
486:
Trustees: Dr. Sanjoy
Bhattacharya, Dr. Claudio Bucolo, Dr. Dorette Ellis, Dr. Shahid Husain, Dr. Goldis Malek, Dr. Najam Sharif, Dr. Dan Stamer, Dr. Chi-ho To, Dr. Heping Xu
517:
Trustees: Dr. Malinda
Fitzgerald, Dr. Ash Jayagopal, Dr. Uday Kompella, Dr. Cameron Millar, Dr. Iok-Hou Pang, Dr. Ganesh Prasanna, Dr. Shusheng Wang, Dr. Christine Wildsoet
73:
241:
139:
213:
111:
220:
118:
227:
125:
209:
107:
87:
of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be
704:
Recent
Advances in Ocular Pharmacology. Symposium proceedings. Novi, Michigan, August 8–10, 1993.J Ocul Pharmacol. 1994 Spring;10(1):1-410.
809:
335:
317:
260:
158:
49:
234:
132:
804:
295:
727:
542:
506:
469:
288:
198:
685:"Association Management | Society Management Services | Federation of American Societies for Experimental Biology"
84:
80:
96:
417:
is the official journal of AOPT. It is a multidisciplinary journal that covers the latest findings related to
385:. The history of AOPT is closely related to the Association for Research in Vision and Ophthalmology (ARVO).
187:
650:
555:
717:
Journal of Ocular
Pharmacology and Therapeutics. Fall 1995, 11(3): 191-192. doi:10.1089/jop.1995.11.191.
573:
545:, Dr. Malinda Fitzgerald, Dr. Juana Gallar, Dr. Peter Kador, Dr. W. Daniel Stamer, Dr. Oliver Zeitz
434:". (Ashwath Jayagopal and Héloïse Ragelle guest editors. The current editor-in-chief of JOPT is
92:
88:
554:
Members of AOPT and societies in the field of eye research, gather every year at the annual
439:
422:
418:
613:
442:) On line ISSN 1557-7732 with an impact factor of 1.782. Affiliated with AOPT and ISOPT
793:
731:
630:
361:
432:
ext
Generation Tissue Engineering: Inspired Models for Ophthalmic Drug Discovery
294:
It may require cleanup to comply with
Knowledge's content policies, particularly
395:
357:
176:
446:( International Symposium on Ocular Pharmacology & Therapeutics Clinical) (
773:
588:
800:
Health care-related professional associations based in the United States
579:
ISOPT (International
Symposium on Ocular Pharmacology and Therapeutics)
365:
715:
The Birth of
Association for Ocular Pharmacology and Therapeutics.
430:). The journal also publishes Special Issues. The next one is "N
79:
Please help to demonstrate the notability of the topic by citing
752:
651:"George C.Y. Chiou, Ph.D. - Texas A&M Health Science Center"
625:
272:
170:
56:
15:
608:
440:
http://medschoolduke.edu/about-us/our-faculty/w-daniel-stamer
427:
594:
ASCRS (American Society of Cataract and Refractive Surgery)
564:
ARVO (Association for Research in Vision and Ophthalmology)
447:
670:
George Chiou is the founder and first president of AOPT.
609:
NAEVR (The National Alliance for Eye and Vision Research)
684:
593:
574:
EVER (European Association for Vision and Eye Research)
583:
568:
563:
287:
A major contributor to this article appears to have a
210:"Association for Ocular Pharmacology and Therapeutics"
108:"Association for Ocular Pharmacology and Therapeutics"
603:
598:
74:
notability guidelines for companies and organizations
674:, 2nd edition. Taylor and Francis. Philadelphia, PA.
489:
Social Media Trustee/Advisor: Dr. Malinda Fitzgerald
350:
Association for Ocular Pharmacology and Therapeutics
578:
541:Trustees: Dr. Abbot Clark, Dr. Julie Crider, Prof.
201:. Unsourced material may be challenged and removed.
753:"Journal of Ocular Pharmacology and Therapeutics"
474:Vice-President/President Elect: Dr. Ash Jayagopal
383:Journal of Ocular Pharmacology & Therapeutics
400:Journal of Ocular Pharmacology and Therapeutics
584:ASRS (American Society of Retinal Specialists)
569:ISER (International Society for Eye Research)
8:
477:Immediate Past President: Dr. Thomas Yurio
50:Learn how and when to remove these messages
336:Learn how and when to remove this message
318:Learn how and when to remove this message
261:Learn how and when to remove this message
159:Learn how and when to remove this message
642:
599:AAO (American Academy of Ophthalmology)
604:AOA (American Optometric Association)
7:
614:Societies of Pharmacology World-Wide
483:Secretary: Dr. Cheryl Rowe-Rendleman
199:adding citations to reliable sources
14:
653:. Medicine.tamhsc.edu. 2007-07-18
31:This article has multiple issues.
532:Vice-President: Dr. Thomas Yorio
298:. Please discuss further on the
277:
175:
61:
20:
589:AGS (American Glaucoma Society)
186:needs additional citations for
39:or discuss these issues on the
535:Treasurer: Dr. Ganesh Prasanna
529:President: Dr. Achim H. Krauss
438:.(Duke University, Durham, NC
379:Journal of Ocular Pharmacology
1:
524:2013-2015 Board of directors
497:2015-2017 Board of directors
480:Treasurer: Dr. Shusheng Wang
463:2018-2020 Board of directors
502:President: Dr. Thomas Yorio
826:
730:. Aopt.org. Archived from
514:Secretary: Dr. Carol Toris
511:Treasurer: Dr. Peter Kador
81:reliable secondary sources
70:The topic of this article
810:Pharmacological societies
774:"AOPT board of directors"
428:http://home.libertpub.com
72:may not meet Knowledge's
538:Secretary: Dr. Jeff Kiel
687:. Faseb.org. 2013-09-24
448:http://isopclinical.com
805:Ophthalmology journals
672:Ophthalmic Toxicology
436:W. Daniel Stamer, PhD
396:peer-reviewed journal
296:neutral point of view
505:Vice-President: Dr.
492:Advisor: Carol Toris
195:improve this article
713:GEORGE C.Y. CHIOU.
394:meetings and the
76:
550:Related societies
346:
345:
338:
328:
327:
320:
291:with its subject.
271:
270:
263:
245:
169:
168:
161:
143:
71:
54:
817:
784:
783:
781:
780:
770:
764:
763:
761:
760:
755:. Liebertpub.com
749:
743:
742:
740:
739:
724:
718:
711:
705:
702:
696:
695:
693:
692:
681:
675:
668:
662:
661:
659:
658:
647:
423:pharmacokinetics
419:pharmacodynamics
341:
334:
323:
316:
312:
309:
303:
289:close connection
281:
280:
273:
266:
259:
255:
252:
246:
244:
203:
179:
171:
164:
157:
153:
150:
144:
142:
101:
65:
64:
57:
46:
24:
23:
16:
825:
824:
820:
819:
818:
816:
815:
814:
790:
789:
788:
787:
778:
776:
772:
771:
767:
758:
756:
751:
750:
746:
737:
735:
728:"AOPT Meetings"
726:
725:
721:
712:
708:
703:
699:
690:
688:
683:
682:
678:
669:
665:
656:
654:
649:
648:
644:
639:
622:
552:
526:
499:
468:President: Dr.
465:
456:
412:
391:
374:
342:
331:
330:
329:
324:
313:
307:
304:
293:
282:
278:
267:
256:
250:
247:
204:
202:
192:
180:
165:
154:
148:
145:
102:
100:
78:
66:
62:
25:
21:
12:
11:
5:
823:
821:
813:
812:
807:
802:
792:
791:
786:
785:
765:
744:
719:
706:
697:
676:
663:
641:
640:
638:
635:
634:
633:
628:
621:
618:
617:
616:
611:
606:
601:
596:
591:
586:
581:
576:
571:
566:
551:
548:
547:
546:
539:
536:
533:
530:
525:
522:
519:
518:
515:
512:
509:
503:
498:
495:
494:
493:
490:
487:
484:
481:
478:
475:
472:
464:
461:
455:
452:
411:
408:
390:
387:
373:
370:
358:ocular disease
344:
343:
326:
325:
285:
283:
276:
269:
268:
183:
181:
174:
167:
166:
69:
67:
60:
55:
29:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
822:
811:
808:
806:
803:
801:
798:
797:
795:
775:
769:
766:
754:
748:
745:
734:on 2013-10-21
733:
729:
723:
720:
716:
710:
707:
701:
698:
686:
680:
677:
673:
667:
664:
652:
646:
643:
636:
632:
629:
627:
624:
623:
619:
615:
612:
610:
607:
605:
602:
600:
597:
595:
592:
590:
587:
585:
582:
580:
577:
575:
572:
570:
567:
565:
562:
561:
560:
557:
549:
544:
543:Filippo Drago
540:
537:
534:
531:
528:
527:
523:
521:
516:
513:
510:
508:
507:Filippo Drago
504:
501:
500:
496:
491:
488:
485:
482:
479:
476:
473:
471:
470:Filippo Drago
467:
466:
462:
460:
453:
451:
449:
445:
441:
437:
433:
429:
424:
420:
416:
409:
407:
405:
401:
397:
388:
386:
384:
380:
371:
369:
367:
363:
359:
355:
351:
340:
337:
322:
319:
311:
301:
297:
292:
290:
284:
275:
274:
265:
262:
254:
243:
240:
236:
233:
229:
226:
222:
219:
215:
212: –
211:
207:
206:Find sources:
200:
196:
190:
189:
184:This article
182:
178:
173:
172:
163:
160:
152:
141:
138:
134:
131:
127:
124:
120:
117:
113:
110: –
109:
105:
104:Find sources:
98:
94:
90:
86:
82:
75:
68:
59:
58:
53:
51:
44:
43:
38:
37:
32:
27:
18:
17:
777:. Retrieved
768:
757:. Retrieved
747:
736:. Retrieved
732:the original
722:
714:
709:
700:
689:. Retrieved
679:
671:
666:
655:. Retrieved
645:
631:Pharmacology
553:
520:
457:
443:
435:
431:
414:
413:
403:
399:
392:
382:
378:
375:
366:therapeutics
362:pharmacology
353:
349:
347:
332:
314:
305:
286:
257:
248:
238:
231:
224:
217:
205:
193:Please help
188:verification
185:
155:
146:
136:
129:
122:
115:
103:
47:
40:
34:
33:Please help
30:
459:worldwide.
454:Composition
251:August 2013
149:August 2013
85:independent
794:Categories
779:2015-05-03
759:2013-10-21
738:2013-10-21
691:2013-10-21
657:2013-10-21
637:References
381:, now the
221:newspapers
119:newspapers
93:redirected
36:improve it
300:talk page
83:that are
42:talk page
620:See also
444:Clinical
389:Activity
308:May 2019
410:Journal
372:History
235:scholar
133:scholar
97:deleted
237:
230:
223:
216:
208:
135:
128:
121:
114:
106:
89:merged
242:JSTOR
228:books
140:JSTOR
126:books
95:, or
556:ARVO
421:and
415:JOPT
404:JOPT
364:and
354:AOPT
348:The
214:news
112:news
626:Eye
406:).
197:by
796::
450:)
398::
368:.
360:,
91:,
45:.
782:.
762:.
741:.
694:.
660:.
426:(
402:(
352:(
339:)
333:(
321:)
315:(
310:)
306:(
302:.
264:)
258:(
253:)
249:(
239:·
232:·
225:·
218:·
191:.
162:)
156:(
151:)
147:(
137:·
130:·
123:·
116:·
99:.
77:.
52:)
48:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
